Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA decides not to approve Indivior's naloxone nasal spray for opioid overdose

Nov. 25, 2015

TRIA Bioscience presents synthetic hapten vaccines

Nov. 23, 2015

First FDA approval of naloxone nasal spray for opioid overdose

Nov. 19, 2015

FDA grants fast track designation to long-acting buprenorphine for opioid addiction

Nov. 5, 2015

FDA grants fast track designation to Insys' sublingual naloxone for opioid overdose

Oct. 30, 2015

U.S. and Italian team reports development of FAAH inhibitors

Oct. 29, 2015

NIAID awards SRI International contract to develop treatments for radiation exposure

Oct. 16, 2015

Addex Therapeutics reports efficacy of ADX-71441 in models of alcohol use disorder

Oct. 14, 2015

Pluristem and FDA agree development pathway for PLX-R18 in ARS

Sep. 21, 2015

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Sep. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...